Vanguard Group Inc Exact Sciences Corp Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$953 Million0.15% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$632 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$629 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$282 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.7MShares$194 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.27B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...